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Sequence homology between the amino-terminal region of the S protein of hepatitis B Virus (HBV) and known fusion
peptides from retroviruses and paramyxoviruses led us to propose that this region might be equally involved in the initial
infective steps of hepadnaviruses. In fact, we showed that a synthetic peptide corresponding to the N-terminus region of the
S protein of HBV had membrane-interacting properties and was able to induce liposome fusion adopting an extended
(b-sheet) conformation (Rodrı´guez-Crespo et al., 1996, 1995). We describe herein studies on the interaction of peptides
derived from the N-terminal region of the S protein of duck (DHBV: Met-Ser-Gly-Thr-Phe-Gly-Gly-Ile-Leu-Ala-Gly-Leu-Ile-Gly-
Leu-Leu) and woodchuck hepatitis B viruses (WHV: Met-Ser-Pro-Ser-Ser-Leu-Leu-Gly-Leu-Leu-Ala-Gly-Leu-Gln-Val-Val) with
liposomes. These peptides were able to induce to a different extent aggregation, lipid mixing, and leakage of internal aqueous
contents from both neutral and negatively charged phospholipid vesicles in a concentration-dependent and pH-independent
manner. Fluorescence depolarization of 1,6-diphenyl-1,3,5-hexatriene-labeled vesicles indicated that both peptides become
inserted into the hydrophobic core of the lipid bilayer. Circular dichroism studies indicated that the DHBV peptide adopts an
extended conformation in the presence of lipids, whereas the WHV peptide displays a high content of a-helical conformation.
Therefore, these results extend our previous findings obtained for human hepatitis B virus to other members of the
hepadnavirus family and suggest that this region of the S protein is important in the initial steps of the infective cycle. © 1999
Academic Press1
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tINTRODUCTION
Hepatitis B virus (HBV), the prototype member of the
epadnavirus family, is a small DNA-containing virus that
nfects human hepatocytes, eliciting important liver pa-
hology (Ganem and Varmus, 1987; Ganem, 1996). Re-
ated hepadnaviruses have also been isolated from
ucks (DHBV), herons (HHBV), ground and arctic squir-
els (GSHV and ASHV) (Testut et al., 1996), woodchucks
WHB), and more recently woolly monkeys (WMHBV)
Lanford et al., 1998; see Ganem, 1996, for a review).
The lack of an efficient in vitro infection system has
ampered systematic studies on the early steps of the
iral life cycle. Liver-derived cell lines are not readily
nfectable, and in addition to primary human hepatocytes
ot being easily accessible, the ability of HBV to infect
hese cells is poor and varies within donors and prepa-
ations (Mabit et al., 1996). In the case of human HBV,
ajor efforts have been undertaken to identify the phys-
ologically relevant hepatocyte receptors involved in vi-
us binding and entry. Numerous candidates, such as
ndonexin-2, albumin receptors, transferrin receptors, or
DL receptors have been proposed (see Treichel et al.,
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 34-91-3944159. E-mail: pacog@solea.quim.ucm.es.133997, for a recent review), although none of them has
een convincingly related to HBV infectivity.
On the other hand, the in vitro infection model of
rimary duck hepatocytes with DHBV has allowed sys-
ematic studies of the virus life cycle, since primary duck
epatocytes are easily obtained from domestic animals
nd conditions for maintenance have been described
Tuttleman et al., 1986). Using noninfectious subviral par-
icles, it has been possible to show that DHBV binds to
cellular receptor on the hepatocyte surface via the preS
omain of the viral L protein (Kuroki et al., 1994). This
eceptor has been identified as gp180, a transmembrane
rotein member of the carboxypeptidase D family (Kuroki
t al., 1995; Tong et al., 1995; Eng et al., 1998). However,
p180 has been found abundantly in duck tissues that do
ot support DHBV infection (Kuroki et al., 1994; Tong et
l., 1995) and transfection of LMH cells (a chicken hep-
toma cell line capable of virus production but refractory
o virus infection) with gp180 does not confer suscepti-
ility to DHBV infection (Kuroki et al., 1995). Very recently,
challer and co-workers have shown that gp180 is not
etected on the hepatocyte cell surface, but concen-
rated in the Golgi apparatus instead, from which it func-
ions by cycling to and from the plasma membrane
Breiner et al., 1998). These authors have also proposed
hat the initial binding of the preS domain of DHBV to0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
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134 RODRI´GUEZ-CRESPO ET AL.p180 must be followed by a species-specific interaction
ith some unknown cellular components that permits
ubsequent infection (Urban et al., 1998).
Following the binding to the appropriate receptor, one
f the most important steps during virus infection is the
usion of the cellular and viral membranes. Recent three-
imensional data of several surface envelope glycopro-
eins of retroviruses, paramyxoviruses, and flavoviruses
as confirmed that in most cases fusion proteins adopt
od-like structures where interweaved a-helices project
he fusion peptides toward the cellular target (Skehel
nd Wiley, 1998, and references therein). This a-helical
undle motif that brings two membranes together is
tarting to be more widely recognized and has been
ound in proteins involved in neurotransmitter release as
ell as intracellular vesicle trafficking complexes.
In the light of sequence similarities between the hep-
dnavirus S protein N-terminal sequences and known
usion peptides from the retrovirus and paramyxovirus
amilies, we proposed that this region might be equally
nvolved in the coalescence of the viral and cellular
embranes during infection (Rodrı´guez-Crespo et al.,
994). Furthermore, the heptad repeats necessary to
orm the coiled-coil structure described in other viruses
ave also been identified in hepadnaviruses (Rodrı´guez-
respo et al., 1995). A synthetic peptide comprising this
redicted fusion region of the S protein interacts with
embranes, promoting liposome aggregation and fusion
n a pH-dependent manner (Rodrı´guez-Crespo et al.,
995), and adopts an extended conformation during the
rocess (Rodrı´guez-Crespo et al., 1996). In this same
egard, evidence for the role of the N-terminal stretch of
he S protein in fusion processes has been achieved
rom experiments showing that treatment of HBV virions
ith certain proteases removed the preS domains, al-
owing the virus to bind to HepG2 cells, fibroblasts, and
eLa cells (Gerlich et al., 1993). Digestion of virions with
8 protease cleaves the S sequence after a Glu residue
t position 2, supposedly exposing the hydrophobic fu-
ion peptide, resulting in productive infection of HepG2
ells. However, treatment with chymotrypsin results in
leavage of the S protein within the fusion peptide 14
mino acids downstream of the V8 site, thus abrogating
nfection (Lu et al., 1996). Assays with low concentrations
f synthetic oligopeptides corresponding to this fuso-
enic sequence of HBV have confirmed the formation of
epG2 cell heterokaryon (fusion) in the presence of
roteolytically processed virions (X. Lu, personal com-
unication).
To ascertain whether the destabilization properties
bserved for the human HBV fusion peptide can also be
scribed to other members of the hepadnavirus family,
he 16-amino-acid oligopeptides corresponding to the
-terminal portions of both DHBV (representative of
vian hepadnaviruses) and WHV (representative of small
ammal hepadnaviruses) were synthesized and tested
or lipid destabilization properties. We describe hereinhe interaction of both peptides with phospholipid vesi-
les as well as the structural features responsible for the
nteraction. These two new peptides interacted with lip-
ds in a pH-independent manner and were more efficient
n terms of fusion and lipid mixing than the HBV fusion
eptide.
RESULTS
esicle aggregation
When the DHBV and WHV N-terminal peptides were
ncubated with phospholipid vesicles an increase in op-
ical density at 360 nm was observed (Fig. 1). This must
e due to the enlargement in vesicle size as a conse-
uence of the aggregation or fusion induced by the
nteraction with the phospholipid molecules. Although
nly the results obtained at pH 7.3 are depicted, similar
ehavior was observed upon interaction of the peptides
ith the vesicles at pH 6.0 and 5.0 (data not shown). The
HBV N-terminal peptide was able to induce aggrega-
ion of vesicles composed of neutral phospholipids (PC)
s well as asolectin vesicles, where acidic phospholip-
ds are the main component (Fig. 1, left). However, this
ncrease in the OD360 of the liposome suspension upon
ddition of the DHBV peptide was more evident in the
ase of asolectin vesicles in the concentration range
ested (up to 30 mM). Under similar experimental condi-
ions, the aggregation induced by the WHV N-terminal
eptide was more limited for both PC and asolectin
iposomes (Fig. 1, right). In fact, the effect of this peptide
n PC vesicles was almost negligible.
FIG. 1. Interaction of DHBV (left) and WHV (right) N-terminal peptides
ith phospholipid vesicles. To 1 ml of asolectin phospholipids (-F-) or
C (-E-) vesicles in medium buffer at pH 7.3, aliquots of peptide from a
tock solution in DMSO were added. The optical density at 360 nm was
easured after incubation of the mixture for 1 h at 37°C. Values of
ontrol samples containing corresponding amounts of DMSO were
ubtracted at each peptide concentration. The lipid concentration was
.14 mM in both cases. The concentration of DMSO was kept below 1%.
he results shown are representative of those obtained for at least
hree different experiments.
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135DHBV AND WHV FUSION PEPTIDESipid mixing
The two N-terminal peptides were also capable of
nducing phospholipid mixing between a population of
esicles containing the fluorescent probes (NBD-PE and
h-PE) and probe-free vesicles (Struck et al., 1981). In
his assay, mixing of phospholipids from labeled and
nlabeled liposomes results in a separation of the do-
or–acceptor pair, with the concomitant decrease in en-
rgy transfer, thus reflecting accurately the degree of
usion (Du¨zgu¨nes et al., 1987). The final extent of lipid
ixing at pH 7.3 for asolectin phospholipids and egg
hosphatidylcholine (PC) vesicles with increasing pep-
ide concentrations is shown in Fig. 2. Both peptides
ere able to induce lipid mixing of both asolectin phos-
holipids and PC vesicles but to a different extent. Al-
ost identical results were obtained in all cases when
he assay was performed at pH 6.0 and 5.0 (data not
hown). In the case of asolectin phospholipids, at a
eptide concentration as low as 10 mM there was al-
eady a noticeable decrease of energy transfer and with
oth peptides saturation was observed at about 30 mM
eptide. The decrease in acceptor surface density cal-
ulated according to the change in energy transfer was
ive- and eightfold for DHBV and WHV, respectively.
hese values indicate that, under the conditions studied,
oth peptides almost induced the complete fusion of
esicles where acidic phospholipids are present, since
he mere aggregation would not result in such a change
n energy transfer (Blumenthal et al., 1983). Lipid mixing
f PC liposomes was less effective. In the peptide con-
entration range studied, DHBV N-terminal peptide in-
uced a linear decrease of energy transfer, resulting in a
ourfold reduction in acceptor surface density. When
HV peptide was added the decrease in energy transfer
ook place from 20 mM peptide and the reduction in
FIG. 2. Lipid mixing induced by the N-terminal peptides. Increasing
oncentrations of the DHBV (left) and WHV (right) fusion peptides
issolved in TFE were added to asolectin phospholipid vesicles (-F-) or
C vesicles (-E-) hydrated in medium buffer at pH 7.3. The mixture was
ncubated for 1 h at 37°C. The phospholipid concentration was 0.14
M. The energy transfer between NBD-PE and Rh-PE was calculated
s indicated under Materials and Methods. The concentration of TFE
as kept below 1%. The results shown are representative of those
btained for three different experiments.-terminal peptides were able to induce the partial fu-
ion of vesicles composed of neutral liposomes.
elease of aqueous contents
The ability of the fusion peptides to destabilize the
ilayer was also assessed by measuring the release of
he aqueous contents of phospholipid vesicles. Lipo-
ome leakage was monitored by the dilution of coencap-
ulated 8-aminonaphtalene-1,3,6-trisulfonic acid (ANTS)
nd its collisional quencher p-xylenebis(pyridinium) bro-
ide (DPX) that leads to a rapid increase in the ANTS
luorescence at 520 nm (Ellens et al., 1985). Figure 3
hows the leakage induced by the synthetic peptides
dded to an asolectin phospholipid suspension at pH
.3. Both peptides were able to interact with the lipid
ilayer and induce the release of the internal content of
he vesicles in a concentration-dependent manner. No
ignificant differences in the percentage of leakage were
ound between the three pH values tested: 7.3, 6.0, and
.0 (data not shown). The peptide concentration needed
o attain the maximum effect was substantially lower
han that needed to induce maximum vesicle aggrega-
ion (Fig. 1) or fusion (Fig. 2). Complete release of the
ntravesicular content (100% leakage) was observed at 5
M DHBV and 14 mM WHV peptide; the fluorescence
ntensity attained at these concentrations was similar to
hat obtained when the liposomes were lysed with the
etergent Triton X-100.
D studies of peptide conformation
Far UV circular dichroism was performed to analyze
he conformational features responsible for the mem-
FIG. 3. Leakage of ANTS/DPX from asolectin phospholipid vesicles
nduced by the N-terminal peptides. Increasing concentrations of
HBV (left) and WHV (right) fusion peptides dissolved in DMSO were
dded to 1 ml of vesicles loaded with ANTS and DPX in medium buffer
t pH 7.3. The vesicle concentration was 0.14 mM. The mixtures were
ncubated at 37°C for 1 h and the fluorescence intensity was measured
t 520 nm. Maxima fluorescence was obtained upon addition of 0.5%
riton X-100. The concentration of DMSO was kept below 1% and had
o effect on vesicle stability. The results shown are representative of
hose obtained for at least three different experiments.
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136 RODRI´GUEZ-CRESPO ET AL.rane destabilizing properties. The spectrum of either
eptide in trifluoroethanol displayed two minima at 220
nd 205 nm which are indicative of a notable proportion
f a-helical structures (Fig. 4). In fact, deconvolution of
hese spectra by the CCA method (Perczel et al., 1991)
enders 37% a-helix, 24% b-sheet, and 39% nonordered
tructure for the DHBV peptide and 40% a-helix, 18%
-sheet, and 42% nonordered structure for the WHV
eptide.
The CD spectra of both peptides in aqueous solution
t pH 7.3 are shown in Fig. 5. The spectra have two
inima, centered at 222–225 nm and below 200 nm,
hich are characteristic of extended structures and non-
rdered conformations. However, in the presence of
imyristoylphosphatidylglycerol (DMPG) vesicles the
econdary structure adopted by the peptides was altered
ignificantly (Fig. 5, solid symbols). At a phospholipid:
eptide molar ratio of 9:1 the CD spectrum of DHBV
eptide exhibited a minimum at around 220 nm, charac-
eristic of extended structures, whereas the CD spectrum
f the WHV peptide displayed a minimum at 205 and a
houlder at 220 nm, characteristic of helical structures
Fig. 5). Incubation of either peptide at higher phospho-
ipid/peptide molar ratios did not change the spectrum
ny further. Hence, upon interaction with phospholipids,
he DHBV peptide restructured into a mostly b-sheet
tructure, whereas the WHV peptide adopted a structure
n which the a-helix predominates over the extended
onformations. Deconvolution of the CD spectra of the
eptides in the presence of DMPG vesicles using the
CA algorithm (Perczel et al., 1991) rendered 29% a-helix
tructure, 57% b-sheet, and 14% nonordered structure for
he DHBV peptide and 42% a-helix structure, 0% b-sheet,
FIG. 4. CD spectra of DHBV (-E-) and WHV (-F-) N-terminal peptides
n TFE. The peptide concentration (90 mM) was determined by amino
cid analysis.D spectra at pH 6.0 and 5.0 or in the presence of
eutral phospholipid vesicles are virtually indistinguish-
ble from those depicted in Fig. 5 (data not shown).
tudies of peptide insertion into phospholipid bilayers
To ascertain the existence of a hydrophobic compo-
ent in the interaction of the N-terminal peptides with
eutral and acidic phospholipids, their effect on the ther-
otropic behavior of these phospholipids has been stud-
ed. Accordingly, we determined the fluorescence polar-
zation of the system after the probe DPH was used to
abel the hydrophobic core of the bilayers. The fluores-
ence depolarization of DPH-labeled dimyristoylphos-
hatidylcholine (DMPC) and dimyristoylphosphatidyl-
erine (DMPS) vesicles with increasing temperatures in
he absence and the presence of peptides at a phospho-
ipid:peptide molar ratio of 12:1 at pH 7.3 are depicted in
ig. 6. Similar results were obtained at pH 6.0 and 5.0.
oth peptides were able to interact with neutral and
cidic phospholipids, although to a greater extent with
he latter. The effect of the peptides on the DMPC tran-
ition temperature is almost negligible, but the amplitude
f the transition is diminished in a concentration-depen-
ent manner, due mainly to the restriction of the acyl
hain mobility in the liquid crystal phase. Under the
ssay conditions, the DHBV peptide reduced the DMPC
ransition amplitude by 50%, whereas the reduction
chieved by the WHV peptide was only 30% (Fig. 6, left).
he DHBV caused a slight decrease in the transition
emperature (from 36.5 to 34°C) of DMPS vesicles, while
FIG. 5. CD spectra of DHBV and WHV N-terminal peptides incubated
ith DMPG vesicles. The circular dichroism spectra of the DHBV (left)
nd WHV (right) were recorded both in the absence (-E-) and the
resence (-F-) of DMPG liposomes at pH 7.3. The appropriate amount
f each of the peptides dissolved in TFE was dried in a tube under a
urrent of nitrogen and the peptide film was subsequently resuspended
n medium buffer at pH 7.3. When desired, a sonicated solution of
MPG vesicles hydrated in the same buffer was added. The peptide
oncentration (80–90 mM) was determined by amino acid analysis. The
ipid/peptide molar ratio was kept at 9:1.
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137DHBV AND WHV FUSION PEPTIDEShe WHV peptide had no effect on it. Both peptides
ecreased the transition amplitude by 70% (DHBV) and
0% (WHV), inducing an almost complete disappearance
f the gel to liquid crystal transition (Fig. 6, right). Hence,
he DHBV peptide is more effective than the WHV pep-
ide in terms of disturbing neutral phospholipids, with the
pposite being true for acidic phospholipids. In every
ase, the DHBV and WHV peptides perturb DMPC and
MPS thermotropic transitions more efficiently than the
BV fusion peptide (unpublished results). These effects
re consistent with a model in which the peptides insert
FIG. 6. Temperature dependence of fluorescence polarization of
PH-labeled phospholipid vesicles. DMPC (left) and DMPS (right) ves-
cles in medium buffer at pH 7.3, labeled with DPH, were incubated with
he DHBV (-F-) and WHV (-n-) N-terminal peptides for 1 h at 37°C. After
ooling the samples, fluorescence polarization was measured at the
ndicated temperature. The phospholipid concentration was 0.14 mM
nd the probe/phospholipid molar ratio was 1/500. The peptide con-
entration, as determined by amino acid analysis, was 12 mM. For both
MPC and DMPS liposomes a control experiment with DMSO (-E-)
lone was performed.
FIG. 7. Electron micrographs of DMPS vesicles in the presence of N-t
HV peptides (12 mM) at pH 7.3 for 1 h at 37°C and the mixtures used
egatively stained with sodium phosphotungstate. DMPS vesicles in
omplex (C). The bars indicate 150 nm (A and C) and 250 nm (B).ilayers and restricting the mobility of the phospholipid
cyl chains.
lectron microscopy studies
Incubation of the peptides with DMPS liposomes
ad an effect on the morphology and size of the phos-
holipid vesicles that can be assessed by electron
icroscopy after negative staining. As shown in Fig.
A, the control DMPS liposomes had a regular shape
nd a average size of 110 6 25 nm. However, at a
eptide concentration of 12 mM, at which both lipid
ixing and leakage of negatively charged vesicles
ere evident, the DHBV peptide induced aggregation
nd liposome fusion leading to the nearly complete
isappearance of the original DMPS vesicles that in-
tead adopted large irregular structures (320 6 70 nm)
Fig. 7B). Interestingly, in the case of the WHV peptide
Fig. 7C), the DMPS liposomes were fragmented into
maller particles (40 6 10 nm), in accordance with the
iminished aggregation levels observed with this pep-
ide (Fig. 1).
DISCUSSION
A great deal of information concerning the fusion of
he viral and cellular plasma or endosomal membranes
as come from the use of synthetic peptides represent-
ng the protein stretch able to interact and destabilize a
ipid bilayer (for a recent review see Pecheur et al., 1999).
n the case of HBV, and mainly due to the fact that
rimary human hepatocytes are not readily obtainable in
reproducibly infectable state (Mabit et al., 1996), the
arly steps of the viral life cycle are not yet understood.
l peptides. DMPS liposomes (0.14 mM) were incubated with DHBV and
glow-discharged Formvar–carbon-coated grids. Afterwards, they were
ence of the peptide (A), DHBV–DMPS complex (B), and WHV–DMPSermina
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138 RODRI´GUEZ-CRESPO ET AL.lthough great progress has been made with the hep-
dnaviral animal infection models, the exact sequence
nvolved in the fusion step has not yet been identified.
owever, based on sequence homology, we have pro-
osed that the N-terminal region of the S protein of HBV
an be involved in the fusion of the virus with the host
embrane (Rodrı´guez-Crespo et al., 1994). Subsequent
tudies performed with a synthetic oligopeptide derived
rom HBV established its ability to induce both fusion and
eakage of phospholipid liposomes in a pH-dependent
anner (Rodrı´guez-Crespo et al., 1995). Although this
usion peptide was flexible enough to adopt an a-helical
tructure when dissolved in trifluoroethanol, its fusion-
ompetent conformation in the presence of lipids ap-
eared to be the b-sheet (Rodrı´guez-Crespo et al., 1996).
n order to extend these results to the other members of
he hepadnavirus family, we have performed studies with
ynthetic oligopeptides corresponding the N-terminal re-
ions of the S glycoproteins of DHBV and WHV. They are
nly partially homologous in sequence and lack both the
lu residue at position 2 and the Phe-Leu-Gly fusogenic
otif (Table 1), present in numerous retroviral and
aramyxoviral fusion peptides (White, 1990; Durell et al.,
997).
Both the DHBV and WHV N-terminal peptides were
ble to cause vesicle aggregation, lipid mixing, and the
eakage of the vesicular internal contents in a concen-
ration-dependent and pH-independent manner. More-
ver, both peptides were significantly more potent in
erms of membrane destabilization than their HBV coun-
erpart. The HBV fusion peptide is able to interact spe-
ifically with anionic phospholipids promoting vesicle
ggregation of asolectin but not of neutral phospholipids.
owever, the DHBV peptide produced a significant effect
n both types of vesicles. More evident was the in-
reased lipid mixing activity of the DHBV and WHV pep-
ides when using asolectin phospholipid vesicles. A pep-
ide concentration value close to 35 mM at pH 7.3 and 20
M at pH 5.0 is needed to attain half of the maximal
nergy transfer value in the case of the HBV fusion
eptide (Rodrı´guez-Crespo et al., 1995), while at pH 7.3,
2 mM DHBV or 8 mM WHV fusion peptides produced
imilar effects. On the other hand, the HBV peptide does
ot induce any decrease of energy transfer at either pH
hen using PC vesicles, while both DHBV and WHV
Amino Acid Sequences of the N-ter
preS S protein
HBV: Ala-Leu-Asn-Met-Glu-Asn-Ile-
DHBV: Lys-Lys-Lys-Met-Ser-Gly-Thr-P
WHV: Ser-Pro-Glu-Met-Ser-Pro-Ser-
Note. The synthetic peptides used in our studies are boxed. The Ph
nd WHV are bold.ere able to promote partial fusion of these vesicles.
owever, the augmented interaction of these two pep-
ides toward vesicles where negatively charged phos-
holipids are present when compared with PC vesicles
lso indicates that the electrostatic contribution of the
eptide–lipid contacts plays a significant role in deter-
ining the studied properties.
The most marked difference when comparing the fu-
ion peptides of DHBV and WHV with HBV is found in the
eakage assay. With asolectin phospholipids liposomes,
concentration value close to 70 mM was needed in the
ase of the HBV fusion peptide in order to generate half
f the maximal fluorescence signal at pH 7.3 (Rodrı´guez-
respo et al., 1995). Concentrations as low as 1 mM
DHBV) or 4 mM (WHV) produce similar effects on iden-
ical vesicles. This increased destabilizing activity of the
HBV and WHV peptides must be a reflection of their
ubtle changes in the amino acid sequence. In this
egard, it must be noted that the Phe and the Gly resi-
ues present in the well-characterized Phe-Leu-Gly tri-
eptide present in the HBV sequence are changed to Ile
nd Ala in the Ile-Leu-Ala (DHBV) and Leu and Ala in the
eu-Leu-Ala (WHV) tripeptides (Table 1). Although the
he to Ile/Leu substitution at position 8 seems to be
onservative enough to maintain a fusogenic activity, the
ubstitution of the Gly by an Ala residue in DHBV and
HBV has a somewhat special interest since this sub-
titution in the fusion peptide of SIV enhanced syncytium
ormation in infected cells sixfold (Bosch et al., 1989).
CD studies have shown that the two peptides charac-
erized in this work are able to adopt different conforma-
ions when challenged in different environments, i.e.,
FE, aqueous solution, and phospholipid vesicles. Be-
ond the ability to interact with lipid membranes, one of
he most important properties of fusion peptides is their
lexibility as well as their capability to adopt different
econdary structures (Durell et al., 1997; Davies et al.,
998). Perhaps, the most studied and better understood
ase would be the influenza hemagglutinin fusion pep-
ide that, according to the crystallographic data, adopts a
old composed of sequential turns in the preactivated,
eutral conformation (Wiley and Skehel, 1987) but inserts
nto lipid membranes adopting a mostly a-helical confor-
ation (Lu¨neberg et al., 1995). This same plasticity is
llustrated by the HIV fusion peptide that evolves from an
f Various Hepadnavirus S Proteins
-Gly-Phe-Leu-Gly-Pro-Leu-Leu-Val-Leu-Gln-Ala-Gly-
-Gly-Ile-Leu-Ala-Gly-Leu-Ile-Gly-Leu-Leu-Val-Ser-
-Leu-Gly-Leu-Leu-Ala-Gly-Leu-Gln-Val-Val-Tyr-Phe-
ly fusogenic motif of HBV and the corresponding sequence in DHBVmini o
Thr-Ser
he-Gly
Ser-Leu
e-Leu-G
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139DHBV AND WHV FUSION PEPTIDES-helix at high lipid/peptide ratios toward a b-strand at
ow lipid/protein ratios (Rafalski et al., 1990).
Fluorescence depolarization studies demonstrated
hat the two fusion peptides insert into the hydrophobic
ore of the phospholipid bilayer. Moreover, in the pres-
nce of DMPG liposomes each peptide seems to be able
o adopt a different conformation. Thus, the DHBV fusion
eptide adopts mostly an extended conformation (b-
heet), whereas the WHV fusion peptide displays a sig-
ificant propensity to fold in an a-helical conformation.
he presence of four Gly residues in the DHBV fusion
eptide (Table 1) could be responsible for its low ability
o adopt the more compact a-helical conformation. Cor-
elation of the behavior of each of the peptides in the
resence of liposomes with the secondary structure data
ed us to infer that the extended conformation of the
HBV peptide is more likely responsible for its ability to
nduce vesicle aggregation, very efficient leakage, and
he massive appearance of fused membranes observed
y electron microscopy photographs. On the other hand,
he WHV peptide in the presence of lipids adopts a
onsiderable percentage of a-helical structure, which
ould be responsible for its low aggregation and potent
eakage capacities. As indicated by energy transfer, the
nsertion of the WHV peptide also induces complete and
artial fusion of liposomes composed of asolectin phos-
holipids and PC, respectively. Therefore, the small ves-
cles which are observed by electron microscopy should
esult from the fragmentation of previously fused lipo-
omes. Examples of viral fusion peptides that adopt
ither extended conformations (Epand et al., 1992; Da-
ies et al., 1998) or a-helical structures (Lear and De-
rado, 1987; Rafalski et al., 1991; Lu¨neberg et al., 1995)
re abundant in the literature.
The information concerning the fusion of HBV and
epatocyte membranes is still scarce and controversial.
y means of a selective PCR technique it has been
emonstrated that infection of primary human hepato-
ytes by HBV was still successful after preincubation of
iral particles at low pH and not affected by the presence
f lysosomotropic agents (Hagelstein et al., 1997). These
esults might suggest that viral passage through an
cidic compartment is not required and fusion of HBV
ith the host cell membrane is a pH-independent event.
n the case of DHBV, and in spite of the availability of an
n vitro infection model, data describing pH-dependent
nd pH-independent viral fusion with the host cell have
een presented. Thus, inhibition of DHBV infection by
ysosomotropic agents such us chloroquine and ammo-
ium chloride has been reported, suggesting a receptor-
ediated endocytosis process followed by a pH-depen-
ent fusogenic step in an acidic vacuole (Offensperger et
l., 1991). However, other studies have pointed toward a
ompletely different strategy of virus infection (Rigg and
challer, 1992; Ko¨ck et al., 1996). The role of pH in
nitiating DHBV infection was investigated using ammo-
ium chloride and monensin as lysosomotropic agents,arrying out control experiments with Semliki Forest Vi-
us or Fowl Plague Virus, which are known to require the
cidic pH of endosomes for infection. Conversely, these
uthors concluded that DHBV infection is not dependent
n low pH and that internalization of DHBV occurred only
etween pH 6.8 and 8.0. Interestingly, uptake of DHBV by
eceptor-mediated endocytosis without passage through
n acidic compartment has been postulated as the in-
ection route (Ko¨ck et al., 1996). One of the key points in
ur data is the fact that the fusogenic activity of the
HBV and WHV peptides was similar at both neutral and
cidic pH values. Neither fusion peptide displayed in-
reased vesicle aggregation, fusion, or leakage at acidic
H values. These data, although indirect, would point to
pH-independent fusion mechanism. However, we have
reviously shown that the HBV S protein N-terminal pep-
ide displayed increased fusogenic activity at acidic pH
Rodrı´guez-Crespo et al., 1995). Sequence comparison of
he synthetic oligopeptides used in these studies reveal
hat the glutamic acid at position 2 of the HBV fusion
eptide is absent in the other two viral sequences (Table
). Partial protonation of this acidic residue at pH 5.0
ogether with the fact that similar secondary structures
re adopted by the HBV peptide at neutral and acidic pH
ight explain the increased fusogenic activity of the HBV
ligopeptide (Rodrı´guez-Crespo et al., 1995, 1996). Nev-
rtheless, this Glu residue might be dispensable during
he fusion process if in vivo a cellular protease is respon-
ible for the generation of the fusion peptide by cleavage
fter the Glu residue. In this respect, it has been recently
escribed that the cleavage of HBV virions by proteases
mmediately after this glutamic acid residue leads to the
ttachment to fibroblasts or HeLa cells, which would not
nteract with HBV under normal conditions (Lu et al.,
996). On the other hand, incubation of DHBV viral par-
icles at low pH promotes translocation of internal preS
omains that could facilitate its cleavage by proteases to
enerate a fusion peptide (Guo and Pugh, 1997).
In conclusion, S protein N-terminal peptides represen-
ative of all the hepadnavirus genera induce aggregation
f phospholipid vesicles, close apposition of mem-
ranes, and destabilization of neutral and acidic phos-
holipid bilayers, the essential steps required for fusion
Bentz et al., 1983). Hence, this protein region might play
n essential role in the fusogenic processes and may be
onsidered an important target in preventing both HBV
ntry and infectivity.
MATERIALS AND METHODS
eagents
DMPG, DMPS, DMPC, PC, N-(7-nitro-2,1,3-benzoxadia-
ol-4-yl)dimyristoylphosphatidylethanolamine (NBD-PE),
nd N-(lissamine rhodamine B sulfonyl)diacylphosphati-
ylethanolamine (Rh-PE) were provided by Avanti Polar
ipids. Soybean asolectin phospholipids were purified
rom type II soybean asolectin (Sigma) by absorption
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140 RODRI´GUEZ-CRESPO ET AL.hromatography in an activated silica gel column in
hloroform. The major components of asolectin phos-
holipids are: phosphatidylethanolamine (39%), phos-
hatidylcholine (24%), and phosphatidylserine (19%) (Pa-
ini et al., 1987). ANTS and DPX were obtained from
olecular Probes. Triton X-100 was purchased from
oehringer Mannheim. All other reagents were obtained
rom Merck and Sigma. All solvents were of HPLC grade.
eptide synthesis
The peptides DHBV, Met-Ser-Gly-Thr-Phe-Gly-Gly-Ile-
eu-Ala-Gly-Leu-Ile-Gly-Leu-Leu, and WHV, Met-Ser-Pro-
er-Ser-Leu-Leu-Gly-Leu-Leu-Ala-Gly-Leu-Gln-Val-Val,
ere synthesized as the C-terminal amide on an auto-
ated multiple peptide synthesizer (AMS 422, Abimed)
sing the solid-phase procedure and standard Fmoc
hemistry in a base of 25 mmol. The synthesis was
arried out on a N-0-Fmoc-DMP resin [4-(29,49-dimethoxy-
henyl-Fmoc-aminomethyl)phenoxy resin (Novabiochem)]
ith Fmoc-protected amino acids activated in situ with
yBOP (benzotriazole-1-yl-oxy-tris-pyrrolidinophosphonium
exafluorophosphate) in the presence of N-methylmor-
holine and 20% piperidine/dimethylformamide for de-
rotection. The protecting side chain groups were as
ollows: Gln (Trt), Ser, and Thr (tBu). Peptides were
leaved from the resin with 82.5% trifluoroacetic acid,
ith 5% phenol, 5% H2O, 5% thioanisole, 2.5% ethane
ithiol as scavengers (King et al., 1990), precipitated, and
ashed with cold methyl tert-butyl ether, water-ex-
racted, lyophilized, and purified in reverse-phase HPLC
sing an Ultrasphere-ODS C18 column (10 3 150 mm)
ith a linear gradient water/35% acetonitrile in 0.1% tri-
luoroacetic acid. Purity of the peptides was assessed to
e more than 95% by reverse-phase HPLC analysis on a
ltrasphere-ODS C18 column (4.6 3 150 mm). Amino acid
nalysis, performed on a Beckman 6300 amino acid
nalyzer, indicated the expected composition. Fast atom
ombardment mass spectrometry yielded the following
esult: m/z 1519.9 and 1584.0 for DHBV and WHV, respec-
ively (calculated 1518.9 and 1584.0). Due to the low
olubility of the peptides in aqueous buffers, a 6 mg/ml
tock solution in dimethyl sulfoxide (DMSO) or trifluoro-
thanol (TFE) was kept perfectly sealed at 220°C and
mployed in the various assays described in this work.
he final organic solvent concentration was always kept
nder 1.5% (v/v) and had no measurable effect on vesicle
tability. A peptide with the sequence ATPAKSEATPAKSE,
ynthesized as described above, was used as control. At
he concentration used (0–70 mM) this peptide had no
easurable effect on any of the assays performed.
esicle preparation
In all cases a lipid film was obtained by drying a
hloroform solution of the lipid under a current of nitro-
en and this film was further kept under vacuum over-ight. The phospholipids were resuspended at a concen-
ration of 1 mg/ml in medium buffer (100 mM NaCl, 5 mM
ES, 5 mM sodium citrate, 5 mM Tris, 1 mM EDTA) at the
ppropriate pH value for 1 h at 37°C and eventually
ortexed vigorously. This suspension was sonicated in a
ath sonicator (Branson 1200) and was subsequently
ubjected to four cycles of extrusion in an Extruder ap-
aratus (Lipex Biomembranes Inc.) with 100-nm polycar-
onate filters (Costar). When encapsulation was neces-
ary, an additional step of four freeze-thawing cycles
as included after the sonication process (see below). A
.14 mM final phospholipid concentration was used in all
he experiments.
esicle aggregation
The optical density variation at 360 nm (OD360) pro-
uced by addition of the peptide from a concentrated
tock solution in DMSO to a phospholipid vesicle sus-
ension, in medium buffer at the appropriate pH, was
easured on a Beckman DU-7 spectrophotometer after
ncubation for 1 h at 37°C. The concentration of DMSO
as kept below 1%. Samples containing equal amounts
f DMSO but in the absence of peptide were always
sed as a control. The final phospholipid concentration
as 0.14 mM.
ipid mixing assay
This was monitored by using the classical fluorescent
robe dilution assay (Struck et al., 1981), in which the
ecrease in the efficiency of the fluorescence energy
ransfer between NBD-PE (energy donor) and Rh-PE (en-
rgy acceptor) incorporated into liposomes, as a conse-
uence of lipid mixing, is monitored. Liposomes, in me-
ium buffer at the appropriate pH, labeled with 1 mol%
BD-PE and either 0.8 or 0.9 mol% Rh-PE (depending on
hether asolectin phospholipids or PC, respectively,
ere used), were mixed in a 1:9 molar ratio with unla-
eled liposomes. Lipid mixing was initiated by addition
f the peptide from a stock solution in TFE. The concen-
ration of TFE was kept below 1%. This organic solvent
as no effect on energy transfer values, as indicated by
ontrol samples containing TFE. The samples were in-
ubated for 1 h at 37°C and the emission spectra were
ecorded in a SLM Aminco 8000 spectrofluorimeter, with
he excitation wavelength set at 450 nm. Both the exci-
ation and emission slits were set at 4 nm. The excitation
olarizer was kept constant at 90° and the emission
olarizer was kept constant at 0° to minimize dispersive
nterference. The efficiency of the energy transfer was
alculated from the ratio of the emission intensities at
30 and 585 nm and the appropriate calibration curve.
he final phospholipid concentration was 0.14 mM.
elease of aqueous contents
Leakage was determined by the ANTS/DPX assay
Ellens et al., 1985), which is based on the dequenching
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141DHBV AND WHV FUSION PEPTIDESf ANTS fluorescence caused by its dilution upon re-
ease of the aqueous contents of one vesicle population
ontaining both ANTS and DPX. It was performed by
oencapsulating 12.5 mM ANTS and 45 mM DPX with 20
M NaCl, 10 mM Tris, pH 7.2, in asolectin phospholipid
esicles. The lipid film was vortexed and the vesicles
ere sonicated in a bath for 30 min. Afterward, the
esicles were subjected to four cycles of freeze-thawing
n liquid nitrogen and passed at least four times through
n Extruder apparatus (Lipex Biomembranes Inc.) with
00-nm polycarbonate filters (Costar). After the vesicles
ith the coencapsulated probe and quencher were
ormed, the whole sample was passed through a Seph-
dex G-75 column (Pharmacia) to separate the vesicles
rom the nonencapsulated material using medium buffer
or elution (Du¨zgu¨nes and Shavnin, 1992). The final phos-
holipid concentration in the assay was 0.14 mM and
edium buffer at the appropriate pH value was used in
ll cases. Leakage was initiated by addition of the pep-
ide from a stock solution in DMSO. The concentration of
MSO was kept below 1%, a value at which there was no
ffect on vesicle integrity. The fluorescence scale was
et to 100% by addition of 0.5% Triton X-100 and 0%
eakage was obtained measuring the fluorescence of the
ontrol vesicles after the addition of DMSO. The suspen-
ions were excited at 385 nm and ANTS emission was
onitored at 520 nm. Both the excitation and emission
lits were set at 4 nm. The excitation and emission
olarizers were kept constant at 90° and 0° to minimize
ispersive interference.
ircular dichroism
Aliquots of peptide from a stock solution at 6 mg/ml in
FE were dried under a stream of nitrogen. These pep-
ide films were dissolved in TFE and TFE/water mixtures
r resuspended in medium buffer (100 mM NaCl, 5 mM
ris, 5 mM citrate, 5 mM MES, 1 mM EDTA) at the
ppropriate pH at a concentration of 120–140 mg/ml. The
pectrum of the peptides in aqueous solution was re-
orded after elimination of peptide aggregates by cen-
rifugation in a Beckman Microfuge E for 15 min. The
ffect of phospholipids on the secondary structure of the
eptides was determined by adding increasing amounts
f liposomes to peptide aliquots. The mixtures were
llowed to react for 1 h at 37°C. When lipids were added,
he samples were subjected to probe sonication in an
ce bath. The clear sonicated solutions were then ana-
yzed by CD.
CD spectra were recorded on a JASCO-715 spectropo-
arimeter at 25°C and with a 1-mm pathlength cell. A
inimum of four spectra was accumulated for each sam-
le. The peptide concentration was determined by amino
cid analysis on a Beckman 6300 automatic amino acid
nalyzer. Deconvolution of the CD data was performed
ccording to the convex constraint analysis (CCA)
ethod (Perczel et al., 1991). This method relies on anlgorithm that calculates the contribution of the second-
ry structure elements that give rise to the original spec-
ral curve without referring to spectra from model sys-
ems. This analysis provides evidence that the CD spec-
rum of a protein contains independent information of at
east four different additive secondary structures.
luorescence polarization
Fluorescence polarization measurements of 1,6-diphe-
yl-1,3,5-hexatriene (DPH) were made on a SLM Aminco
000C spectrofluorimeter equipped with 10-mm Glan-
hompson polarizers. DMPC and DMPS (0.14 mM), con-
aining DPH at a ratio of 1 molecule of fluorophore for
very 500 phospholipid molecules, was hydrated at the
ppropriate pH and extruded as indicated above. The
eptide was added from a stock concentrated solution in
MSO. The concentration of DMSO was kept below
.5%. Peptide–vesicle mixtures were incubated for 1 h at
7°C and then cooled. The excitation was set at 365 nm
nd emission was measured at 425 nm, after equilibra-
ion of the samples at the indicated temperature. The
emperature in the cuvette was maintained with a Poly-
tat Huber circulating water bath.
lectron microscopy
Samples of DMPS vesicles (obtained by extrusion
hrough a 0.1-mm pore diameter polycarbonate filter) at
.14 mM lipid concentration were incubated with DHBV
r WHV fusion peptides at a final concentration of 12 mM
or 1 h at 37°C. Subsequently, the lipid–peptide mixtures
ere applied to a glow-discharged 400-mesh Formvar–
arbon-coated grid for 2 min. Excess fluid was drawn
way with filter paper. Samples were then negatively
tained with 2% (w/v) phosphotungstic acid at pH 7.0 and
xamined by using a Zeiss EM 902 (Jena, Germany)
ransmission electron microscope operating at 80 kV.
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